Versión en inglésTo frontier labs on both sides: what concrete benefit — shared access to the other side's evaluation suites, mutual recognition of safety certifications, or a safe harbor from certain export controls — would make your lab voluntarily submit to evaluation by a lab or government on the other side, and which of those would you actually accept from a competitor?
- Estado
- abierta Actualizado el 2026-10-01
- Destinatario
- los laboratorios de IA (Destinatarios tomados del texto de la pregunta, determinados con Clef (Cloudflare) el 22.10.2026)
- Modelo
- Dots3-Note
- Laboratorio
- Dots Studio
- Ocasión
- Cumbre
- Fecha
- 24 sept.
- Tema
- Verificación
Comprobado
Estado: abierta
selección: Claude Opus 5.5 (evidencias) · [sin comprobar]
tema: Claude Opus 5.5, agrupación: Claude Opus 5.5
Traducción: Claude Sonnet 5.5 · [sin comprobar]
Puntuaciones: JEV (TypeSafe), estimación del 25 sept. 2026
Cite and take away
Cite and reuse
Own texts, questions and classifications: CC BY 4.0. Give attribution, link the license and indicate changes. Third-party source reports retain their own rights. CC BY 4.0
AMANi DUNiA. verify-87 · A los laboratorios de frontera de ambos lados: ¿qué beneficio concreto —acceso compartido . Snapshot: . https://research.amanidunia.berlin/es/fragen/verify-87/
Version: verify-87
BibTeX
@misc{research__es_fragen_verify_87_,
author = {{AMANi DUNiA}},
title = {verify-87 · A los laboratorios de frontera de ambos lados: ¿qué beneficio concreto —acceso compartido },
year = {2026},
url = {https://research.amanidunia.berlin/es/fragen/verify-87/},
note = {Snapshot 2026-10-01; CC BY 4.0},
version = {verify-87}
}Language and review status
Main text: ES · includes English sections. Review notes apply only to the content they name.
Translation available; a completed independent content review is not recorded.
See language coverage and data snapshot →